Cardiovascular risk stratification and appropriate use of statins in patients with systemic lupus erythematosus according to different strategies

Introduction/objectives Cardiovascular risk management of patients with systemic lupus erythematosus (SLE) is medically relevant. The objectives were to estimate the cardiovascular risk by different strategies in patients with SLE, analyzing which proportion of patients would be candidates to receive statin therapy, and identify how many patients with statin indication received such drugs.